The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: -0.50 (-2.50%)
Spread: 1.00 (5.263%)
Open: 19.50
High: 20.00
Low: 19.50
Prev. Close: 20.00
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 2017 Market Update

10 Oct 2017 07:00

RNS Number : 1237T
Iofina PLC
10 October 2017
 

 

10 October 2017

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

Q3 2017 Market Update

 

IOsorb® plants perform well, construction of IO#7 on track

 

Iofina, specialists in the exploration and production of iodine and halogen based specialty chemical derivatives, today provides an update to the market regarding its activities in the third quarter ("Q3" or the "Period") of 2017.

 

The Group produced 125 metric tonnes ("MT") of crystalline iodine in the Period at its four operating IOsorb® plants for a total year to date production of 360.5 MT. This output puts Iofina on track to meet or exceed the Company's forecasted H2 2017 production of 225-240 MT as it moves into the fourth quarter.

 

Progress to disassemble IO#3 and construct IO#7 is continuing within the Company's anticipated timeline and budget, with the Company expecting IO#7 to be online in early 2018. In addition, Iofina Chemical had a successful Period and has continued the trend identified at the interim stage with a continued, diverse product mix of halogen based derivative products that have seen improved margins over those historically achieved in this business unit.

 

Commenting, President and CEO Dr. Tom Becker, stated: 

''The third quarter of 2017 was a landmark period for Iofina. The Group produced more iodine than expected and began implementing management's strategic expansion plans by starting the construction of IO#7, at a time when global iodine prices continue to recover.

 

"We expect IO#7 to be online in early 2018, which will take our total number of IOsorb® plants back to five. IO#7 will immediately increase production and reduce our overall plant level iodine unit production costs, thereby well positioning the Group for the future." 

 

Enquiries:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Emily Morris

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Harriet Jackson

Yellow Jersey

Tel: +44 (0)7544 275 882

 About Iofina:

Iofina specialises in the exploration and production of iodine, halogen based specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDUKSNRBVARRAA
Date   Source Headline
4th Dec 20127:00 amRNSProduction Update
17th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSNotice of Results
16th Aug 20127:00 amRNSCommissioning of Plant
31st Jul 20127:00 amRNSCompletion of Construction of IO#1 IOsorb Plant
20th Jun 20122:25 pmRNSResult of AGM
20th Jun 20127:00 amRNSPurchase of Iodine Extraction Facility
7th Jun 20127:00 amRNSHolding(s) in Company
25th May 20127:00 amRNSFinal Results
25th May 20127:00 amRNSPlacing to raise £4.3 million
19th Apr 20127:56 amRNSAppointment of Investec as Nomad and Sole Broker
10th Apr 20129:39 amRNSHolding(s) in Company
5th Apr 20128:05 amRNSPurchase of Production Site & Recycling Initiative
2nd Apr 20125:01 pmRNSHolding(s) in Company
29th Mar 201212:11 pmRNSHolding(s) in Company
19th Mar 20127:00 amRNSCorporate Update
25th Nov 20117:00 amRNSDirector/PDMR Shareholding
24th Nov 20117:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSHolding(s) in Company
27th Sep 20117:00 amRNSHalf Yearly Report
9th Aug 20117:00 amRNSTrading Update
30th Jun 20114:42 pmRNSResult of AGM
24th Jun 201111:42 amRNSHolding(s) in Company
8th Jun 20117:00 amRNSAmbrian Partners Appointed Joint Broker to Iofina
7th Jun 20117:00 amRNSIofina Reports Audited Full Year Financials
31st May 20116:03 pmRNSHolding(s) in Company
4th May 20114:32 pmRNSHolding(s) in Company
4th May 20114:29 pmRNSHolding(s) in Company
28th Apr 201112:58 pmRNSHolding(s) in Company
20th Apr 20117:00 amRNSPlacing
13th Apr 20116:28 pmRNSHolding(s) in Company
25th Mar 20117:00 amRNSContract Win
18th Mar 20117:00 amRNSHolding(s) in Company
1st Mar 20113:35 pmRNSHolding(s) in Company
27th Jan 20115:27 pmRNSHolding(s) in Company
12th Jan 20114:40 pmRNSSecond Price Monitoring Extn
12th Jan 20114:35 pmRNSPrice Monitoring Extension
3rd Dec 201012:46 pmRNSOperations Update
19th Oct 20105:30 pmRNSHolding(s) in Company
29th Sep 20109:26 amRNSHolding(s) in Company
28th Sep 20107:01 amRNSInterim Results
28th Sep 20107:00 amRNSAppointment of Finance Director
31st Aug 20107:00 amRNSFourth Extraction and Collection Agreement Signed
16th Jul 20105:57 pmRNSHolding in Company - Replacement
16th Jul 20105:02 pmRNSHoldings in Company
7th Jul 201010:00 amRNSResult of AGM
4th Jun 20107:00 amRNSFinal Results
20th May 20107:00 amRNSNew Agreement Signed and Operations Update
4th May 20107:00 amRNSIssuance of Permit
14th Apr 20107:00 amRNSThird Party Iodine Agreement Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.